Red Oak Archives - CDR – Chain Drug Review

CVS Health unveils outlook for fiscal 2018

January 15, 2018 by Scot Meyer and Chain Drug Review CVS Health, CVS Health's 2018 earnings outlook, David Denton, Larry Merlo, Red Oak 2018, Issue 01-15-2018, Issues, News

WOONSOCKET, R.I. — CVS Health executives expressed confidence in the company’s growth strategy earlier this month, and also noted that the recently passed tax overhaul packaged should boost its cash flow by an estimated $1.2 billion. The remarks came in a conference call following an announcement of CVS Health’s 2018 earnings outlook. CVS Health said

CVS Health gives update on 2018 outlook

January 5, 2018 by Scot Meyer and Chain Drug Review CVS Health, CVS Pharmacy, David Denton, Larry Merlo, Red Oak Business, Leading Headlines, Retail News

WOONSOCKET, R.I. — In an update for investors, CVS Health executives expressed confidence in its growth outlook and noted that the recently passed tax overhaul package should boost its cash flow by an estimated $1.2 billion. The remarks came yesterday in a conference call after the company’s announcement of its earnings expectations for 2018. CVS